Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rauh

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Archiv Der Pharmazie|September 23, 2003
New cyanopeptide-derived low molecular weight thrombin inhibitorsGregor Radau, Jana Gebel, Daniel Rauh
Bioorganic & Medicinal Chemistry|July 22, 2020
Corrigendum to "Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR" [Bioorg. Med. Chem. 23, 2015, 2767-2780]Debjit Basu, André Richters, Daniel Rauh
ACS Medicinal Chemistry Letters|January 29, 2016
Hope and Disappointment: Covalent Inhibitors to Overcome Drug Resistance in Non-Small Cell Lung CancerJulian Engel, Jonas Lategahn, Daniel Rauh
Angewandte Chemie (International Ed. in English)|November 28, 2017
Lessons To Be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung CancerJonas Lategahn, Marina Keul, Daniel Rauh
Medchemcomm|August 29, 2018
Chemical modulation of transcription factorsBianca Wiedemann, Jörn Weisner, Daniel Rauh
Bioorganic & Medicinal Chemistry|May 16, 2015
Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFRDebjit Basu, André Richters, Daniel Rauh
ACS Chemical Biology|December 20, 2012
Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural featuresZhizhou Fang, Christian Grütter, Daniel Rauh
Angewandte Chemie (International Ed. in English)|February 10, 2015
Monitoring ligand-induced conformational changes for the identification of estrogen receptor agonists and antagonistsSvenja C Mayer-Wrangowski, Daniel Rauh
Journal of Molecular Biology|January 20, 2004
Understanding protein-ligand interactions: the price of protein flexibilityDaniel Rauh, Gerhard Klebe, Milton T Stubbs
ACS Chemical Biology|March 17, 2018
Augmented Reality in Scientific Publications-Taking the Visualization of 3D Structures to the Next LevelPatrik Wolle, Matthias P Müller, Daniel Rauh
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Archiv Der Pharmazie|September 23, 2003
New cyanopeptide-derived low molecular weight thrombin inhibitorsGregor Radau, Jana Gebel, Daniel Rauh
Bioorganic & Medicinal Chemistry|July 22, 2020
Corrigendum to "Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR" [Bioorg. Med. Chem. 23, 2015, 2767-2780]Debjit Basu, André Richters, Daniel Rauh
ACS Medicinal Chemistry Letters|January 29, 2016
Hope and Disappointment: Covalent Inhibitors to Overcome Drug Resistance in Non-Small Cell Lung CancerJulian Engel, Jonas Lategahn, Daniel Rauh
Angewandte Chemie (International Ed. in English)|November 28, 2017
Lessons To Be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung CancerJonas Lategahn, Marina Keul, Daniel Rauh
Medchemcomm|August 29, 2018
Chemical modulation of transcription factorsBianca Wiedemann, Jörn Weisner, Daniel Rauh
Bioorganic & Medicinal Chemistry|May 16, 2015
Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFRDebjit Basu, André Richters, Daniel Rauh
ACS Chemical Biology|December 20, 2012
Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural featuresZhizhou Fang, Christian Grütter, Daniel Rauh
Angewandte Chemie (International Ed. in English)|February 10, 2015
Monitoring ligand-induced conformational changes for the identification of estrogen receptor agonists and antagonistsSvenja C Mayer-Wrangowski, Daniel Rauh
Journal of Molecular Biology|January 20, 2004
Understanding protein-ligand interactions: the price of protein flexibilityDaniel Rauh, Gerhard Klebe, Milton T Stubbs
ACS Chemical Biology|March 17, 2018
Augmented Reality in Scientific Publications-Taking the Visualization of 3D Structures to the Next LevelPatrik Wolle, Matthias P Müller, Daniel Rauh
Pageof 16